Stay updated on Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded revision entry: v3.3.4 to the record history and removed v3.3.3. This is an update to the page's version history entries.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision v3.3.3 added; HHS Vulnerability Disclosure and Revision v3.3.2 removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe record history now includes a new revision entry (v3.3.2) replacing the previous revision (v3.2.0). There are no changes to study details or status.SummaryDifference0.1%

- Check67 days agoChange DetectedThe funding status notice that previously appeared on the page was removed.SummaryDifference0.4%

- Check81 days agoChange DetectedNew screenshot shows an extended list of version history entries with updated recruitment and study status across multiple versions. The changes reflect more recent updates to the study record.SummaryDifference0.1%

- Check109 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference10%

Stay in the know with updates to Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.